Showing results (731-740 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|May 25, 2013
Clinical and economic benefit of enzymatic debridement of pressure ulcers compared to autolytic debridement with a hydrogel dressingCurtis Waycaster, Catherine T MilneJournal of Medical Economics|July 18, 2013
Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studiesLin Xie, Wenhui Wei, Chunshen Pan, et al.Journal of Medical Economics|July 2, 2013
Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trialI M Majer, H Gelderblom, W B van den Hout, et al.Journal of Medical Economics|December 6, 2012
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in SwedenNiklas Bergvall, Magnus Tambour, Freddie Henriksson, et al.Journal of Medical Economics|February 1, 2013
Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysisElizabeth L Eby, Ping Wang, Bradley H Curtis, et al.Journal of Medical Economics|February 1, 2013
Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamoleMichelle Friedman, James Spalding, Smita Kothari, et al.Journal of Medical Economics|January 10, 2013
Economic consequences of sequencing biologics in rheumatoid arthritis: a systematic reviewSean D Sullivan, Rafael Alfonso-Cristancho, Josh Carlson, et al.Journal of Medical Economics|January 11, 2013
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 yearsMerriKay Oleen-Burkey, Anissa Cyhaniuk, Eric SwallowJournal of Medical Economics|December 12, 2012
Comparative effectiveness research in the United States: a progress reportSean D Sullivan, Josh J Carlson, Ryan N HansenJournal of Medical Economics|February 28, 2013
Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IRJay Lin, Wing Chow, Myoung S Kim, et al.Pageof 241